Prognostic factors of oral mucosal melanoma: Histopathological analysis in a retrospective cohort of 82 cases

Histopathology

Volumn 67, Issue 4, 2015, Pages 548-556

  Song, Hao ^a   Wu, Yunteng ^a   Ren, Guoxin ^a   Guo, Wei ^a   Wang, Lizhen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell type; Epithelioid cell; Melanoma; Metastasis; Oral mucosa; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CELL DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MOUTH MUCOSA; MUCOSAL MELANOMA; OVERALL SURVIVAL; PIGMENTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; DISEASE FREE SURVIVAL; IMMUNOLOGY; KAPLAN MEIER METHOD; MELANOMA; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84941600175     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12692     Document Type: Article

References (28)

1. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol. 2007; 43; 116-121.
2. Rapini RP, Golitz LE, Greer RO Jr, Krekorian EA, Poulson T. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer 1985; 55; 1543-1551.
3. Takagi M, Ishikawa G, Mori W. Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis. Cancer 1974; 34; 358-370.
4. Broomhall C. Malignant melanoma of the oral cavity in Ugandan Africans. Br. J. Surg. 1967; 54; 581-584.
5. Gavriel H, McArthur G, Sizeland A, Henderson M. Review. Mucosal melanoma of the head and neck. Melanoma Res. 2011; 21; 257-266.
6. Lourenco SV, Sangüeza MA, Sotto MN et al. Primary oral mucosal melanoma: a series of 35 new cases from South America. Am. J. Dermatopathol. 2009; 31; 323-330.
7. Temam S, Mamelle G, Marandas P et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005; 103; 313-319.
8. Yang X, Ren GX, Zhang CP et al. Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma. BMC Cancer 2010; 10; 623.
9. Wu Y, Zhong Y, Li C, Song H, Guo W, Ren G. Neck dissection for oral mucosal melanoma: caution of nodular lesion. Oral Oncol. 2014; 50; 319-324.
10. Wang X, Wu HM, Ren GX, Tang J, Guo W. Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient. J. Oral Maxillofac. Surg. 2012; 70; 1192-1198.
11. Barker BF, Carpenter WM, Daniels TE et al. Oral mucosal melanomas: the Westop Banff Workshop Proceedings. Western Society of Teachers of Oral Pathology. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1997; 83; 672-679.
12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American joint committee on cancer staging manual. 7th ed. New York: Springer, 2009; 97-100.
13. Prasad ML, Busam KJ, Patel SG, Hoshaw-Woodard S, Shah JP, Huvos AG. Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch. Pathol. Lab. Med. 2003; 127; 997-1002.
14. Prasad ML, Patel S, Hoshaw-Woodard S et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am. J. Surg. Pathol. 2002; 26; 883-892.
15. Kerr EH, Hameed O, Lewis JS Jr, Bartolucci AA, Wang D, Said-Al-Naief N. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. Int. J. Surg. Pathol. 2012; 20; 37-46.
16. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors. Cancer 2004; 100; 1657-1664.
17. Guo W, Wang X. Images in clinical medicine. Gingival melanoma. N. Engl. J. Med. 2013; 369; 1452.
18. Patel SG, Prasad ML, Escrig M et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24; 247-257.
19. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am. J. Ophthalmol. 1983; 96; 502-509.
20. McLean MJ, Foster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch. Ophthalmol. 1977; 95; 48-58.
21. Damato BE, Paul J, Foulds WS. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br. J. Ophthalmol. 1996; 80; 102-108.
22. Wiesner T, Obenauf AC, Murali R et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat. Genet. 2011; 43; 1018-1021.
23. Koopmans AE, Verdijk RM, Brouwer RW et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod. Pathol. 2014; 27; 1321-1330.
24. Harbour JW, Onken MD, Roberson ED et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330; 1410-1413.
25. Lourenco SV, Fernandes JD, Hsieh R et al. Head and neck mucosal melanoma: a review. Am. J. Dermatopathol. 2014; 36; 578-587.
26. Larsen TE, Grude TH. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 2. The relation of cell type, pigmentation, atypia and mitotic count to histological type and prognosis. Acta Pathol. Microbiol. Scand A 1978; 86A; 513-522.
27. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 2006; 48; 754-762.
28. Clark WH Jr, Elder DE, Guerry DT et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl Cancer Inst. 1989; 81; 1893-1904.